Kansas City Life Insurance Company (KCLI)
Kansas City, MO, US
Operating in 49 U.S. states and the District of Columbia, Kansas City Life Insurance Company delivers a wide array of financial protection solutions. Its comprehensive product range covers individual and group policies for life, health, and accident insurance. The company also provides various annuity products, including immediate annuities tied to life contingencies, in addition to specialized supplementary contracts. This firm was established in 1985 and maintains its corporate headquarters in Kansas City, Missouri.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.61% | +2.43% | -0.98% | -5.73% | -0.95% | -2.68% | +9.08% | +38.84% | -30.55% | -24.54% | +304.66% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Insurance - Life: +10.6%-1.1% Q1'26: -1.0% (vs Q1'25)
-
EPS growth Insurance - Life: +13.4%-319.6% Q1'26: +421.1% (vs Q1'25)
-
FCF margin FCF growth · Insurance - Life: +31.7%-28.4% Q1'26: -49.9% (vs Q1'25)
-
EBIT margin Insurance - Life: +12.4%-6.6% Q1'26: +3.5% (vs Q1'25)
-
ROIC Insurance - Life: +1.0%-4.9% Q1'26: +2.5% (vs Q1'25)
-
Share dilution Insurance - Life: +0.4%+0.0% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Insurance - Life: -1.05×0.00× Q1'26: 0.00× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 1994 actual |
Dec 1995 actual |
Dec 2009 actual |
Dec 2010 actual |
Dec 2011 actual |
Dec 2012 actual |
Dec 2013 actual |
Dec 2014 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
393.45M
est: 4.99B (-92.1%)
|
408.79M
est: 5.73B (-92.9%)
|
420.65M
est: 9.39B (-95.5%)
|
431.37M
est: 14.93B (-97.1%)
|
419.31M
est: 13.96B (-97.0%)
|
441.62M
est: 13.05B (-96.6%)
|
483.74M
est: 12.21B (-96.0%)
|
465.27M
est: 11.41B (-95.9%)
|
441.93M
est: 10.67B (-95.9%)
|
446.01M
est: 9.98B (-95.5%)
|
451.52M
est: 9.33B (-95.2%)
|
455.82M
est: 8.72B (-94.8%)
|
512.40M
est: 8.16B (-93.7%)
|
509.28M
est: 7.63B (-93.3%)
|
494.65M
est: 7.13B (-93.1%)
|
475.95M
est: 6.67B (-92.9%)
|
494.97M
est: 6.23B (-92.1%)
|
| EBITDA |
91.95M
est: 48.47M (+89.7%)
|
65.21M
est: 58.49M (+11.5%)
|
19.37M
est: 27.59M (-29.8%)
|
37.55M
est: 50.68M (-25.9%)
|
42.90M
est: 47.38M (-9.5%)
|
66.73M
est: 44.30M (+50.6%)
|
48.73M
est: 41.42M (+17.6%)
|
47.68M
est: 38.73M (+23.1%)
|
47.56M
est: 36.21M (+31.3%)
|
36.52M
est: 33.86M (+7.9%)
|
35.10M
est: 31.66M (+10.9%)
|
22.99M
est: 29.60M (-22.3%)
|
37.82M
est: 27.68M (+36.6%)
|
24.45M
est: 25.88M (-5.5%)
|
20.89M
est: 24.20M (-13.7%)
|
-14.17M
est: 22.62M (-162.6%)
|
74.57M
est: 21.15M (+252.5%)
|
| EBIT |
57.42M
est: 140.49M (-59.1%)
|
59.95M
est: 161.33M (-62.8%)
|
16.45M
est: 27.59M (-40.4%)
|
34.76M
est: 50.68M (-31.4%)
|
39.70M
est: 47.38M (-16.2%)
|
59.50M
est: 44.30M (+34.3%)
|
44.46M
est: 41.42M (+7.3%)
|
42.98M
est: 38.73M (+11.0%)
|
42.20M
est: 36.21M (+16.5%)
|
31.04M
est: 33.86M (-8.3%)
|
29.37M
est: 31.66M (-7.2%)
|
17.19M
est: 29.60M (-41.9%)
|
29.45M
est: 27.68M (+6.4%)
|
15.91M
est: 25.88M (-38.5%)
|
12.92M
est: 24.20M (-46.6%)
|
-20.76M
est: 22.62M (-191.7%)
|
69.31M
est: 21.15M (+227.7%)
|
| Net Income |
37.38M
est: 32.58M (+14.7%)
|
41.74M
est: 40.67M (+2.6%)
|
10.73M
est: 17.86M (-39.9%)
|
22.30M
est: 30.95M (-28.0%)
|
26.13M
est: 28.94M (-9.7%)
|
41.15M
est: 27.06M (+52.1%)
|
30.06M
est: 25.30M (+18.8%)
|
29.99M
est: 23.66M (+26.8%)
|
29.23M
est: 22.12M (+32.1%)
|
22.32M
est: 20.68M (+7.9%)
|
51.54M
est: 19.34M (+166.5%)
|
15.67M
est: 18.08M (-13.3%)
|
24.43M
est: 16.91M (+44.5%)
|
15.17M
est: 15.81M (-4.0%)
|
10.70M
est: 14.78M (-27.6%)
|
-16.22M
est: 13.82M (-217.4%)
|
54.92M
est: 12.92M (+325.1%)
|
| SGA |
—
|
—
|
103.36M
est: 132.25M (-21.8%)
|
100.63M
est: 148.03M (-32.0%)
|
—
est: 138.41M (-100.0%)
|
110.17M
est: 129.41M (-14.9%)
|
110.62M
est: 121.00M (-8.6%)
|
101.74M
est: 113.14M (-10.1%)
|
97.26M
est: 105.78M (-8.1%)
|
101.48M
est: 98.91M (+2.6%)
|
102.90M
est: 92.48M (+11.3%)
|
101.72M
est: 86.47M (+17.6%)
|
—
est: 80.85M (-100.0%)
|
—
est: 75.59M (-100.0%)
|
—
est: 70.68M (-100.0%)
|
—
est: 66.08M (-100.0%)
|
—
est: 61.79M (-100.0%)
|
| EPS |
3.04
est: 2.23 (+36.3%)
|
3.38
est: 3.16 (+7.0%)
|
0.93
est: 1.94 (-51.9%)
|
1.95
est: 3.03 (-35.5%)
|
2.29
est: 2.84 (-19.2%)
|
3.71
est: 2.66 (+39.7%)
|
2.73
est: 2.48 (+10.1%)
|
2.74
est: 2.32 (+18.4%)
|
2.75
est: 2.17 (+26.7%)
|
2.30
est: 2.03 (+13.3%)
|
5.32
est: 1.90 (+180.0%)
|
1.62
est: 1.79 (-9.2%)
|
2.52
est: 1.67 (+50.9%)
|
1.57
est: 1.57 (+0.3%)
|
1.11
est: 1.47 (-24.2%)
|
-1.67
est: 1.37 (-222.3%)
|
5.67
est: 1.28 (+343.0%)
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-08 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-07 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-30 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-29 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-28 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-27 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-24 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-23 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-22 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-20 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-17 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Walter Edwin Bixby LLIF | President, Chief Executive Officer & Vice Chairman of the Board | 789.6K | male |
| Mark Alan Milton CERA MAAA | Senior Vice President, Actuary & Director | 461.1K | male |
| David Arnold Laird | Senior Vice President of Finance & Director | 381.9K | male |
| Jennifer Pieper | Vice President & Controller | — | — |
| Alan Craig Mason Jr. | Senior Vice President, General Counsel, Secretary & Director | — | male |
| Holly Ann Ropp | Assistant Vice President of Corporate Communications | — | female |
| Stephen Edward Ropp | Senior Vice President of Operations | — | male |
| Thomas Deacy | Vice President of Investments | — | — |
| Robert Milroy | Vice President of New Business & Underwriting | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for KCLI
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
